Wright Medical Group (WMGI) Posts Q4 Loss of $0.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Wright Medical Group (WMGI) Posts Q4 Loss of $0.29
February 22, 2017 8:59 AM EST
BMO Capital Markets analyst Joanne Wuensch reiterates Outperform rating and raises price target on Wright Medical Group NV (NASDAQ: WMGI) to $31 (from 427), suggesting a positive outlook, as the company reported 2016 fourth quarter revenues and EPS above consensus, offering 2017 guidance above consensus estimates.
Wuensch... More
February 22, 2017 7:14 AM EST
Jefferies reiterated a Buy rating and $30.00 price target on Wright Medical Group (NASDAQ: WMGI) following the company's 4Q earnings report.
Analyst Raj Denhoy commented, "4Q was positive on numerous fronts: +15% underlying sales growth driven by Shoulders, Biologic, and Ankles; 11.7% EBITDA margins, a new high... More
February 22, 2017 6:26 AM EST
Needham and & Company analyst Mike Matson reiterates Hold rating on Wright Medical Group NV (NASDAQ: WMGI), as the company delivered 2016 fourth quarter revenue and EBITDA above consensus, while offering 2017 revenue guidance above consensus projections.
Matson comments, "WMGI's 4Q16 revenue and EBITDA beat consensus, and... More
